- Investing Ideas
- /
- Global Top Stock Picks from Analysts
Global Top Stock Picks from Analysts
Results
3826
Companies which are more than 50% undervalued based on analyst price target.
3,826 companies
Galecto
Market Cap: US$3.7m
A clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases.
GLTO
US$2.79
7D
-6.4%
1Y
-83.6%
Quoin Pharmaceuticals
Market Cap: US$3.6m
A late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States.
QNRX
US$6.36
7D
2.6%
1Y
-76.6%
60 Degrees Pharmaceuticals
Market Cap: US$3.6m
A specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States.
SXTP
US$2.39
7D
-2.0%
1Y
-81.9%
CNS Pharmaceuticals
Market Cap: US$3.6m
A clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors.
CNSP
US$1.36
7D
23.6%
1Y
-99.7%
1414 Degrees
Market Cap: AU$5.5m
Engages in developing and commercializing silicon-based thermal storage technology.
14D
AU$0.019
7D
11.8%
1Y
-76.3%
Eprcomunicazione
Market Cap: €3.1m
Provides strategic consulting and communication services for companies and organizations in Italy.
EPRB
€1.23
7D
7.0%
1Y
-3.1%
Getech Group
Market Cap: UK£2.6m
Provides government advisory, geoscience, and geospatial services.
GTC
UK£0.017
7D
-10.5%
1Y
-82.6%
Edible Garden
Market Cap: US$3.4m
Edible Garden AG Incorporated, together with its subsidiaries, operate as a controlled environment agriculture farming company.
EDBL
US$2.33
7D
10.4%
1Y
-97.8%
Palisade Bio
Market Cap: US$3.4m
A clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases.
PALI
US$0.73
7D
-12.5%
1Y
-88.3%
Enveric Biosciences
Market Cap: US$3.3m
A biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders.
ENVB
US$1.43
7D
17.9%
1Y
-88.4%
CERo Therapeutics Holdings
Market Cap: US$3.3m
An immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer.
CERO
US$0.59
7D
-19.6%
1Y
-99.5%
Eyenovia
Market Cap: US$3.3m
An ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States.
EYEN
US$1.15
7D
11.7%
1Y
-98.3%
Tharimmune
Market Cap: US$3.3m
A clinical-stage biotechnology company, engages in the development of therapeutic candidates for rare, inflammatory, and oncologic conditions with high unmet need in the United States.
THAR
US$1.44
7D
-12.7%
1Y
-73.7%
Artelo Biosciences
Market Cap: US$3.3m
A clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States.
ARTL
US$1.03
7D
3.0%
1Y
-22.6%
Image Scan Holdings
Market Cap: UK£2.5m
Through its subsidiary 3DX-Ray Limited, engages in the manufacture and sale of portable X-ray systems in the United Kingdom, Europe, the Middle East, Africa, Asia, Indian Subcontinent, and the Americas.
IGE
UK£0.018
7D
-2.7%
1Y
33.3%
Windtree Therapeutics
Market Cap: US$3.2m
A biotechnology company, focuses on the development of therapeutics for the treatment of acute cardiovascular diseases.
WINT
US$0.90
7D
-0.1%
1Y
-99.6%
Rosslyn Data Technologies
Market Cap: UK£2.4m
Engages in the development and provision of data analytics software, data capture, data mining, and workflow management in the United Kingdom, Europe, and the United States.
RDT
UK£0.035
7D
7.6%
1Y
-63.6%
Sprint Bioscience
Market Cap: SEK 30.7m
A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.
SPRINT
SEK 0.45
7D
-20.6%
1Y
-66.2%
Biodexa Pharmaceuticals
Market Cap: US$3.2m
A clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan cancers of the brain.
BDRX
US$1.29
7D
-3.0%
1Y
-95.3%
Expion360
Market Cap: US$3.1m
Designs, assembles, manufactures, and sells lithium iron phosphate (LiFePO4) batteries and supporting accessories in the United States.
XPON
US$1.05
7D
27.1%
1Y
-99.5%
BSA
Market Cap: AU$4.8m
Offers communications and utilities infrastructure, and property solutions in Australia.
BSA
AU$0.064
7D
3.2%
1Y
-90.9%
Telesia
Market Cap: €2.8m
Operates in the digital media and multimedia sector in Italy.
TLS
€1.15
7D
0%
1Y
-42.5%
Ensysce Biosciences
Market Cap: US$3.1m
A clinical-stage pharmaceutical company, develops prescription drugs for severe pain relief in opioid misuse, abuse, and overdose in the United States.
ENSC
US$2.07
7D
-4.6%
1Y
-75.2%
Iconovo
Market Cap: SEK 29.7m
Develops and licenses inhalation medications in Sweden.
ICO
SEK 1.32
7D
1.1%
1Y
-85.1%
Spruce Biosciences
Market Cap: US$3.0m
A biopharmaceutical company, focuses on developing and commercializing novel therapies for neurological disorders.
SPRB
US$0.066
7D
-7.6%
1Y
-92.1%
Revel Collective
Market Cap: UK£2.3m
Operates premium bars located in towns or city center high streets in the United Kingdom.
TRC
UK£0.0015
7D
0%
1Y
-90.0%
Premier Health of America
Market Cap: CA$4.2m
Engages in the provision of staffing and outsourced service solutions for healthcare needs in Canada.
PHA
CA$0.095
7D
26.7%
1Y
-78.2%
Thinc Collective
Market Cap: SEK 29.0m
Offers systems, communication, and structure services in Sweden and internationally.
THINC
SEK 1.70
7D
-5.0%
1Y
n/a
SpaceandPeople
Market Cap: UK£2.2m
Provides commercial and promotional space and retail solutions for businesses to promote and acquire customers in shopping centers, retail parks, railway stations, and other locations in the United Kingdom and Germany.
SAL
UK£1.18
7D
0%
1Y
35.8%
Revelation Biosciences
Market Cap: US$3.0m
Operates as a clinical-stage biopharmaceutical company that focuses on the development and commercialization of immune system therapeutics and diagnostics.
REVB
US$3.18
7D
9.7%
1Y
-89.2%
Super League Enterprise
Market Cap: US$2.9m
Super League Enterprise, Inc. creates and publishes content experiences and media solutions across immersive platforms in the United States and internationally.
SLE
US$0.15
7D
-58.3%
1Y
-91.0%
My Size
Market Cap: US$2.8m
An omnichannel e-commerce platform, provides AI-driven software as a service measurement solution for fashion ecommerce companies in Israel and Spain.
MYSZ
US$1.26
7D
0.8%
1Y
-73.4%
Cerinnov Group
Market Cap: €2.4m
Designs, manufactures, and markets of machines and equipment for the ceramics, heat treatment, and glass industries in France, rest of Europe, the Americas, Asia, Oceania, and the Middle East.
ALPCV
€0.47
7D
0%
1Y
-74.8%
DBT
Market Cap: €2.4m
Provides charging solutions for electric vehicles, retractable terminals for access control and dissuasion, distribution terminals for power and current transformers in France and internationally.
ALDBT
€0.49
7D
3.1%
1Y
-65.4%
Beneficient
Market Cap: US$2.7m
A technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States.
BENF
US$0.32
7D
8.9%
1Y
-93.2%
Galilee Energy
Market Cap: AU$4.1m
Through its subsidiaries, engages in the exploration and production of oil and gas properties in Australia, the United States, and Chile.
GLL
AU$0.006
7D
0%
1Y
-83.8%